0 Items - $0.00
A to Z

Alternative structural projections:


8- Bromo- β- phenyl- 1, N²- ethenoguanosine- 3', 5'-cyclic monophosphate ( 8-Br-PET-cGMP ), sodium salt

Cat. No.: P 003
CAS No.: [144510-04-3]
Shipping: ambient
Product Name Price (net) Qty
Cat. No.: P 003-10
Unit: 10 µmol / ~5.5 mg

For other salt forms or metabolites please inquire. Potent membrane-permeant activator of both isozymes I α and I β of cGMP-dependent protein kinase while only a poor stimulator of type II. Common agonists such as 8-Br-cGMP (Cat. No. B 004) or 8-pCPT-cGMP (Cat. No. C 009) mainly activate kinase subtypes I α and II. 8-Br-PET-cGMP is one of the best activators of isozyme I β and one of the best cyclic nucleotide muscle relaxants. Detailed technical information and updated reference list available. Reference: Sekhar et al., Mol. Pharmacol., 42, 103 - 108 (1992).

Cat. No. P 003
CAS number [144510-04-3]
Purity > 98% HPLC
Salt form Sodium
Storage temperature -20°C / -4°F
Molecular formula C₁₈H₁₄BrN₅O₇P · Na
Molecular weight [g/mol] 546,2
Modifications 8-cGMP
Target PKG (cGK) Activator
Lipophilicity 2.83
Absorption max [nm] 256
Molar extinction coefficient ε [L·mol⁻¹·cm⁻¹] 40000
  • 1. Herfindal L., Nygaard G., Kopperud R., Krakstad C., Doeskeland S. O.Selheim F., Biochem. Biophys. Res. Commun., 437, 603 - 608 (2013), "Off-Target Effect of the Epac Agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 Receptors in Blood Platelets"
  • 2. Werner K., Schwede F., Genieser H.-G., Geiger J.Butt E., Naunyn Schmiedebergs Arch. Pharmacol., 384, 169 - 176 (2011), "Quantification of cAMP and cGMP Analogs in Intact Cells: Pitfalls in Enzyme Immunoassays for Cyclic Nucleotides"
  • 3. Poppe H., Rybalkin S. D., Rehmann H., Hinds T. R., Tang X.-B., Christensen A. E., Schwede F., Genieser H.-G., Bos J. L., Doeskeland S. O., Beavo J. A.Butt E., Nature Methods, 5, 277 - 278 (2008), "Cyclic Nucleotide Analogs as Probes of Signaling Pathways"
  • 4. Lohmann S. M.Walter U., Frontiers Biosci., 10, 1313 - 1328 (2005), "Tracking Functions of cGMP-dependent Protein Kinase"
  • 5. Gao Y. S., Dhanakoti S., Trevino E. M., Wang X. H., Sander F. C., Portugal A. D.Raj J. U., Am. J. Physiol.-Lung Cell Mol. Physiol., 286, 786 - 792 (2004), "Role of cGMP-dependent Protein Kinase in Development of Tolerance to Nitric Oxide in Pulmonary Veins of Newborn Lambs"
  • 6. Piper A. S.Large W. A., J. Physiol., 555, 397 - 408 (2004), "Single cGMP-activated Ca2+dependent Cl-channels in Rat Mesenteric Artery Smooth Muscle Cells"
  • 7. Genieser H.-G., Bos J. L., Christensen A. E., Doeskeland S. O., Havemann U., Manzau U., Rehmann H.Schwede F., Poster #THP016 Montreal, 12, 0 - 0 (2004), "Analogues of Cyclic AMP to Distinguish Between PKA and Epac"
  • 8. Gambaryan S., Geiger J., Schwarz U. R., Butt E., Begonja A., Obergfell A.Walter U., Blood, 103, 2593 - 2600 (2004), "Potent Inhibition of Human Platelets by cGMP Analogs Independent of cGMP-dependent Protein Kinase"
  • 9. Jensen B. O., Selheim F., Doeskeland S. O., Gear A. R. L.Holmsen H., Blood, 104, 2775 - 2782 (2004), "Protein Kinase A Mediates Inhibition of the Thrombin-Induced Platelet Shape Change by Nitric Oxide"
  • 10. Christensen A. E.Doeskeland S. O., Handbook of Cell Signaling Academic Press/Elsevier Science San Diego CA, 2, 549 - 554 (2003), "Cyclic Nucleotide Analogs as Tools to Investigate Cyclic Nucleotide Signaling"
  • 11. Deng W., Parbhu-Patel A., Meyer D. J.Baker D. A., Biochem. J., 374, 559 - 565 (2003), "The Role of Two Novel Regulatory Sites in the Activation of the cGMP-dependent Protein Kinase from Plasmodium Falciparum"
  • 12. Teede H., van der Zypp A.Majewski H., Clin. Sci., 100, 473 - 479 (2001), "Gender Differences in Protein Kinase G-mediated Vasorelaxation of Rat Aorta"
  • 13. Francis S. H.Corbin J. D., Crit. Rev. Clin. Lab. Sci., 36, 275 - 328 (1999), "Cyclic Nucleotide-Dependent Protein Kinases: Intracellular Receptors for cAMP and cGMP Action"
  • 14. Pfeifer A., Ruth P., Dostmann W., Sausbier M., Klatt P.Hofmann F., in Rev. Physiol. Biochem. Pharmacol. Berlin / Springer, 135, 105 - 149 (1999), "Structure and Function of cGMP-Dependent Protein Kinases"
  • 15. Hardy P., Abran D., Hou X., Lahaie I., Peri K. G., Asselin P., Varma D. R.Chemtob S., Circ. Res., 83, 721 - 729 (1998), "A Major Role for Prostacyclin in Nitric Oxide-Induced Ocular Vasorelaxation in the Piglet"
  • 16. Chu D.-M., Francis S. H., Thomas J. W., Maksymovitch E. A., Fosler M.Corbin J. D., J. Biol. Chem., 273, 14649 - 14656 (1998), "Activation by Autophosphorylation or cGMP Binding Produces a Similar Apparent Conformational Change in cGMP-Dependent Protein Kinase"
  • 17. Vaandrager A. B., Smolenski A., Tilly B. C., Houtsmuller A. B., Ehlert E. M. E., Bot A. G. M., Edixhoven M., Boomaars W. E. M., Lohmann S. M.De Jonge H. R., Proc. Natl. Acad. Sci. USA, 95, 1466 - 1471 (1998), "Membrane Targeting of cGMP-dependent Protein Kinase is Required for Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channel Activation"
  • 18. Tolloczko B., Jia Y. L.Martin J. G., Amer. J. Physiol., 16, 865 - 871 (1997), "Effects of cAMP on Serotonin Evoked Calcium Transients in Cultured Rat Airway Smooth Muscle Cells"
  • 19. Vaandrager A. B., Edixhoven M., Bot A. G. M., Kroos M. A., Jarchau T., Lohmann S. M., Genieser H.-G.De Jonge H. R., J. Biol. Chem., 272, 11816 - 11823 (1997), "Endogenous Type II cGMP-Dependent Protein Kinase Exists as a Dimer in Membranes and can be Functionally Distinguished from the Type I Isoforms"
  • 20. Craven P. A., Studer R. K., Felder J., Phillips S.Derubertis F. R., Diabetes, 46, 671 - 81 (1997), "Nitric Oxide Inhibition of Transforming Growth Factor-Beta and Collagen Synthesis in Mesangial Cells"
  • 21. Vaandrager A. B., Tilly B. C., Smolenski A., Schneider-Rasp S., Bot A. G. M., Edixhoven M., Scholte B. J., Jarchau T., Walter U., Lohmann S. M., Poller W. C.De Jonge H. R., J. Biol. Chem., 272, 4195 - 4200 (1997), "cGMP Stimulation of Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channels Co-Expressed with cGMP-Dependent Protein Kinase Type II but not Type I(Beta)"
  • 22. Chu D.-M., Corbin J. D., Grimes K. A.Francis S. H., J. Biol. Chem., 272, 31922 - 31928 (1997), "Activation by Cyclic GMP Binding Causes an Apparent Conformational Change in cGMP-Dependent Protein Kinase"
  • 23. Studer R. K., De Rubertis F. R.Craven P. A., J. Amer. Soc. Nephrol., 7, 999 - 1005 (1996), "Nitric Oxide Suppresses Increases in Mesangial Cell Protein Kinase C, Transforming Growth Factor Beta and Fibronectin Synthesis Induced by Thromboxane"
  • 24. Wei J. Y., Cohen E. D., Yan Y.-Y., Genieser H.-G.Barnstable C. J., Biochemistry, 35, 16815 - 16823 (1996), "Identification of Competitive Antagonists of the Rod Photoreceptor cGMP-Gated Cation Channel: Beta-Phenyl-1,N(2)-Etheno-Substituted cGMP Analogues as Probes of the cGMP-Binding Site"
  • 25. Wei J. Y., Cohen E. D., Yan Y.-Y., Genieser H.-G.Barnstable C. J., American Society for Neuroscience, 0, 880 - 0 (1996), "PET-substituted cGMP Analogs: Novel Antagonists of Rod Photoreceptor cGMP-gated Channel"
  • 26. Genieser H.-G., Bucher B.Butt E., 9th International Conference on Second Messenger & Phosphoproteins, 0, 0 - 0 (1995), "Rp-8-Br-PET-cGMPS, A New Potent Inhibitor of Cyclic GMP-dependent Protein Kinase"
  • 27. Francis S. H.Corbin J. D., Adv. Pharmacol., 26, 115 - 170 (1994), "Progress in Understanding the Mechanism and Function of Cyclic GMP-Dependent Protein Kinase"
  • 28. Sekhar K. R., Hatchett R. J., Shabb J. B., Wolfe L., Francis S. H., Wells J. W., Jastorff B., Butt E., Chakinala M. M.Corbin J. D., Mol. Pharmacol., 42, 103 - 108 (1992), "Relaxation of Pig Coronary Arteries By New and Potent cGMP Analogs That Selectively Activate Type I alpha Compared to Type I beta cGMP-Dependent Protein Kinase"

Show more